Financials Neogen Corporation

Stocks

NEOG

US6404911066

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 15/10/2026 BST			5-day change	1st Jan Change
12.27 ^USD	+1.15%		+4.78%	+75.54%

10-13	Inside the Fight Against Food Recalls	MT
10-08	Neogen Eyes Up To Low-Double-Digit Revenue Growth by Fiscal 2031	MT

Projected Income Statement: Neogen Corporation

Projected Income Statement - Annual - Neogen Corporation

Fiscal Period: May	2022	2023	2024	2025	2026	2027	2028	2029
Net sales ¹	527.2	822.4	924.2	894.7	870.4	886.6	874.5	929.6
Change	-	56.01%	12.37%	-3.2%	-2.71%	1.86%	-1.36%	6.3%
EBITDA ¹	82.31	205.4	213.2	184.2	177.8	180.9	190.2	213.5
Change	-	149.56%	3.77%	-13.57%	-3.49%	1.75%	5.12%	12.25%
EBIT ¹	58.62	37.52	58.66	-1,061	-21.6	28.4	31.55	20.7
Change	-	-36%	56.37%	-1,908.63%	97.96%	231.48%	11.09%	-34.39%
Interest Paid ¹	-	-52.8	-67.03	-68.51	-57.6	-54.1	-48.97	-50.2
Earnings before Tax (EBT) ¹	60.21	-22.04	-14.3	-1,133	-9	-41.77	-28.77	-29.5
Change	-	-136.61%	35.1%	-7,821.08%	99.21%	-364.07%	31.13%	-2.55%
Net income ¹	48.31	-22.87	-9.421	-1,092	-7.9	-33.93	-23.73	-23.7
Change	-	-147.34%	58.81%	-11,491.59%	99.28%	-329.54%	30.06%	0.14%
Announcement Date	26/07/22	27/07/23	30/07/24	29/07/25	30/07/26	-	-	-

¹USD in Million

Estimates

Projected Income Statement - Quarterly - Neogen Corporation

Fiscal Period: May	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2	2028 Q3	2028 Q4	2029 Q1
Net sales ¹	130.5	128.2	140.1	132.3	230	218.3	241.8	229	229.6	228.8	236.8	217	231.3	221	225.5	209.2	224.7	211.2	225.3	222.8	224.8	214.4	228.2	217.8	223.3	212.4	227.4	216.5
Change	-	-1.74%	9.24%	-5.53%	73.81%	-5.12%	10.79%	-5.3%	0.28%	-0.36%	3.49%	-8.37%	6.59%	-4.44%	2.03%	-7.22%	7.41%	-6%	6.68%	-1.11%	0.88%	-4.61%	6.45%	-4.57%	2.53%	-4.9%	7.09%	-4.79%
EBITDA ¹	18.3	12.7	23.89	27.02	64.05	51.27	63.08	52.37	55.1	52.74	52.95	43.71	51.38	48.51	40.62	35.47	48.75	48.2	45.4	41.6	44.3	46.03	50.13	43	42	48	53	45
Change	-	-30.6%	88.11%	13.1%	137.07%	-19.95%	23.03%	-16.98%	5.21%	-4.28%	0.4%	-17.45%	17.54%	-5.58%	-16.27%	-12.68%	37.43%	-1.12%	-5.81%	-8.37%	6.49%	3.91%	8.91%	-14.23%	-2.33%	14.29%	10.42%	-15.09%
EBIT ¹	12.47	16.98	18.03	19.79	-7.656	15.68	23.42	19.14	14.46	12.02	13.04	2.257	-457.5	5.415	-611.2	-16.09	-5.377	-3.3	3.1	-1.8	2.8	10	12.8	-0.7	0.2	3.9	10.1	1.5
Change	-	36.15%	6.18%	9.8%	-138.68%	304.86%	49.36%	-18.31%	-24.41%	-16.88%	8.46%	-82.69%	-20,369.56%	101.18%	-11,386.89%	97.37%	66.58%	38.63%	193.94%	-158.06%	255.56%	257.14%	28%	-105.47%	128.57%	1,850%	158.97%	-85.15%
Charge d'intérêts ¹	-	-	-	-	-	-16.82	-16.95	-16.67	-16.17	-16.67	-17.52	-17.62	-17.37	-17.04	-16.48	-15.52	-14.26	-13.9	-13.9	-13.8	-13.55	-13.55	-13.55	-13.1	-13.1	-13.1	-13.1	-13.1
Earnings before Tax (EBT) ¹	-	-	18.91	6.659	-34.09	-2.26	7.65	1.663	-3.747	-5.822	-6.399	-15.61	-476.6	-9.727	-631.2	43.81	-20.36	-20.3	-12.1	-14.9	-11.4	-9.533	-5.2	-13.8	-12.9	-9.2	-3	-11.6
Change	-	-	-	-64.78%	-611.95%	93.37%	438.5%	-78.26%	-325.32%	-55.38%	-9.91%	-143.93%	-2,953.19%	97.96%	-6,389.17%	106.94%	-146.48%	0.31%	40.39%	-23.14%	23.49%	16.37%	45.45%	-165.38%	6.52%	28.68%	67.39%	-286.67%
Net income ¹	-	-	14.96	5.209	-41.84	8.19	5.572	1.503	-3.487	-2.022	-5.415	-12.61	-456.3	-10.96	-612.2	36.34	-15.92	-17	-11.3	-11.9	-9.233	-8	-4.367	-10.9	-10.2	-7.2	-2.3	-9.2
Change	-	-	-	-65.18%	-903.24%	119.57%	-31.97%	-73.03%	-332%	42.01%	-167.8%	-132.85%	-3,518.7%	97.6%	-5,487.26%	105.94%	-143.82%	-6.76%	33.53%	-5.31%	22.41%	13.36%	45.42%	-149.62%	6.42%	29.41%	68.06%	-300%
Announcement Date	21/12/21	24/03/22	26/07/22	27/09/22	05/01/23	30/03/23	27/07/23	10/10/23	09/01/24	09/04/24	30/07/24	10/10/24	10/01/25	09/04/25	29/07/25	09/10/25	08/01/26	09/04/26	30/07/26	06/10/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Neogen Corporation

Fiscal Period: May	2022	2023	2024	2025	2026	2027	2028	2029
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	26/07/22	27/07/23	30/07/24	29/07/25	30/07/26	-	-	-

Estimates

Cash Flow Forecast: Neogen Corporation

Fiscal Period: May	2021	2022	2023	2024	2025	2026
CAPEX ¹	-	24.43	65.76	111.4	104.6	51.3
Change	-	-	169.18%	69.44%	-6.13%	-50.95%
Free Cash Flow (FCF) ¹	37.31	47.76	35.64	-45.36	-32.87	69.5
Change	-	28.02%	-25.38%	-227.29%	27.53%	311.42%
Announcement Date	30/07/21	27/07/22	15/08/23	30/07/24	30/07/25	30/07/26

¹USD in Million

Estimates

Forecast Financial Ratios: Neogen Corporation

Fiscal Period: May	2021	2022	2023	2024	2025	2026	2027	2028	2029
Profitability
EBITDA Margin (%)	-	15.61%	24.98%	23.06%	20.59%	20.43%	20.41%	21.75%	22.97%
EBIT Margin (%)	-	11.12%	4.56%	6.35%	-118.59%	-2.48%	3.2%	3.61%	2.23%
EBT Margin (%)	-	11.42%	-2.68%	-1.55%	-126.65%	-1.03%	-4.71%	-3.29%	-3.17%
Net margin (%)	-	9.16%	-2.78%	-1.02%	-122.06%	-0.91%	-3.83%	-2.71%	-2.55%
FCF margin (%)	-	-	-3.01%	-	-	-	-	-	-
FCF / Net Income (%)	-	-	108.13%	-	-	-	-	-	-
Profitability
ROA	5.62%	5.5%	2.23%	1.03%	0.01%	-0.4%	-	-	-
ROE	7.78%	5.59%	-1.14%	-0.3%	-41.88%	-0.38%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	8%	12.06%	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	32.01%	52.27%	-	-	-	-	-
CAPEX / FCF (%)	-	-	-265.91%	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	0.45	-0.12	-0.04	-5.03	-0.04	-0.1533	-0.11	-0.105
Change	-	-	-126.67%	66.67%	-12,475%	99.2%	-283.32%	28.26%	4.55%
Nbr of stocks (in thousands)	-	107,797	216,221	216,608	217,038	217,673	218,306	218,306	218,306
Announcement Date	-	26/07/22	27/07/23	30/07/24	29/07/25	30/07/26	-	-	-